Applied Filter(s) Clear Filter



Therapy Area: Infectious Disease


Global Infection Control Market

Report ID: PNPH1262 Industry: Pharma & Biotech Therapy Area: Infectious Disease

The global infection control market in terms of revenue was estimated to be worth $50.0 billion in 2023 and is poised to reach $58.3 billion by 2030, growing at a CAGR of 3.1% from 2023 to 2030.The new research study consists of an analysis of market industry trends. The new research study includes industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behavior in the market.

Global Antimicrobial Susceptibility Market

Report ID: PNPH1193 Industry: Pharma & Biotech Therapy Area: Infectious Disease

The worldwide antimicrobial susceptibility testing market is expected to increase at a 5.5% CAGR from 2022 to 2027, from an anticipated value of US$3.6 billion in 2022 to US$4.7 billion in 2027. The Antimicrobial Susceptibility Testing (AST) Technology Market is expanding due to factors such as rising infectious illness prevalence, increased antibiotic resistance, and favourable government measures to minimise infectious disease burden.

Global Anticoccidial Drugs Market

Report ID: PNPH1174 Industry: Pharma & Biotech Therapy Area: Infectious Disease

In April 2019, Creative Diagnostics developed anticoccidial drug assay products to test anticoccidial drug residues in animals. This advancement and awareness of anticoccidial drugs will impact the trend of the anticoccidial drugs market. Growing awareness of animal health and zootonic diseases is expected to increase acceptance of anticoccidial drugs. The rising carnivorous population and reliance on bovine products is expected to be a driving factor for the growth of the anticoccidial drugs market. Additionally, the increase in research and development of veterinary drugs is expected to provide growth opportunities for anticoccidial drugs. 

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!


One of our marquee services We profile relevant start-up companies in the market.


Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.